September 2012 - Page 11 of 17

WednesdaySep 12, 2012 2:45 pm

National Graphite Corp. (NGRC) Completes Electro-Magnetic Survey at Chedic/Voltaire Graphite Property in Nevada

National Graphite, the domestic mineral development firm focused on graphite and precious metal projects in North America, was pleased to report today that the StrataGem Electro-Magnetic Survey on the company's flagship graphite site in northwestern Nevada (100% interest via the agreement with GeoXplor Corp. from April 24, 2012), the 400-acre Chedic/Voltaire property in Carson City, has been successfully completed. Given the lack of natural graphite production here in the U.S. and China's dominant role with 75% of global output (with India in second ahead of export markets like Brazil or Canada), this strategically critical resource demands domestic development and NGRC…

WednesdaySep 12, 2012 1:30 pm

Transcept Pharmaceuticals, Inc. (TSPT) Finishes Patient Enrollment in Phase 2 Trial of TO-2061

Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. One such product in the company's pipeline is TO-2061, a drug to be used in patients with obsessive-compulsive disorder. The company announced today that it has completed patient enrollment in its Phase 2 clinical trial evaluating TO-2061 which is added as an adjunctive therapy for patients with obsessive-compulsive order (OCD). These patients have not responded adequately to standard first-line treatment with a currently approved OCD medication. These medications include the selective serotonin re-uptake inhibitors…

WednesdaySep 12, 2012 1:12 pm

Altairnano, Inc. (ALTI) and Shenhua Science & Technology Sign Memorandum of Understanding

It was recently announced that an agreement was signed by three parties to develop, deploy, and promote industrial applications of lithium titanate-based energy storage systems in China. Altairnano, Shenhua Science & Technology (Shenhua S&T) and its research affiliate, and the National Institute of Clean and Low-carbon Energy (NICE) signed a memorandum of understanding (MOU) that calls for the launch of a pilot project to deploy and test an Altairnano ALTI-ESS Advantage System at one of Shenhua's wind farms in China. As part of the MOU, a joint working group comprised of members of all three organizations was formed to define…

WednesdaySep 12, 2012 12:43 pm

MusclePharm Corp. (MSLP) Means Critical Nutrition for Serious Athletes

MusclePharm’s diverse series of nutritional supplements for athletes and healthy lifestyle consumers is a combination of products aimed at providing critical nutrients for superior athletic performance, such as amino acids, metabolism boosters, and mineral support, all 100% free of banned substances. Each offering is the result of testing and evaluation by doctors and scientists, as well as performing athletes, using MusclePharm’s state-of-the-art performance facility. For example, MusclePharm’s Core Series Creatine is a specially formulated, slow-digesting anti-catabolic blend of 5 different types of protein. Protein, critical to every athlete and bodybuilder, builds muscle mass, strength, and power. MusclePharm makes it easy…

WednesdaySep 12, 2012 12:11 pm

Terra Tech Corp. (TRTC) Spammed Aggressively

We have observed emails spamming Terra Tech Corp. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics page, visit www.basics.qualitystocks.net Let us hear your thoughts below:

WednesdaySep 12, 2012 11:21 am

SFDA Approval Granted for Dehaier Medical Ltd. (DHRM) DHR-CPAP-C5 Device for Treating Sleep Apnea

Dehaier Medical Systems announced that it has obtained State Food and Drug Administration approval for DHR-CPAP-C5, one of the company’s primary proprietary homecare medical devices. The validity period for the SFDA approval is four years. Continuous positive airway pressure (CPAP) has become the first-line treatment for obstructive sleep apnea syndrome (OSAS), as well as for some forms of central sleep apnea. CPAP works by creating a pneumatic splint for the upper airway. Pressurized air is sent through air tubing and a mask (generally a nose mask) and through the nose to the upper airway by means of a flow generator.…

WednesdaySep 12, 2012 9:32 am

Chairman and CEO of Loans4Less.com, Inc. (LFLS) Featured in Exclusive Interview with SmallCapVoice

SmallCapVoice.com today announced that a new audio interview with Loans4Less.com is now available. The interview can be accessed at http://smallcapvoice.com/blog/9-11-12-smallcapvoice-interview-with-loans4less-com-inc-otc-lfls. Mr. Steven M. Hershman, Chairman & CEO of Loans4Less.com, Inc., called into SmallCapVoice.com to go over the business model and market for the company. The interview includes an overview of the business strategies used by management, the goals for the company in 2012, and the major achievements of the company to date. Loans4Less.com is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+…

WednesdaySep 12, 2012 8:53 am

QualityStocks is on the Apple App Store!

Do you have an iPhone, iPad, or iPod Touch? If so, good news! You can access the latest micro-cap and small-cap news, in-depth articles on emerging growth companies, our currently featured companies, real-time Twitter updates and Facebook posts, and new “Ones to Watch!” It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. Our team works very hard to bring the same high-quality content you expect from QualityStocks to your mobile devices. To check out the new app, search for “QualityStocks” on your device or visit http://dtg.fm/app Let us hear…

TuesdaySep 11, 2012 4:21 pm

Cytomedix, Inc. (CMXI) to Highlight FDA-Cleared AutoloGel System at Symposium on Advanced Wound Care Fall 2012

Cytomedix, a developer of advanced autologous adult stem cell technologies for wound and tissue repair, will display its AutoloGel™ System in three poster presentations at the upcoming Symposium on Advanced Wound Care Fall 2012 (Sept 12-14) at the Baltimore Convention Center. Cytomedix will also host a booth at the symposium where attendees and clinicians can learn more how AutoloGel can produce autologous platelet rich plasma (PRP) gel for use in wound management. The system is the only PRP device cleared by the U.S. Food and Drug Administration (FDA) for this application. Presenting AutoloGel at the SAWC Fall 2012 provides exposure…

TuesdaySep 11, 2012 2:44 pm

SmallCapVoice: Omega Commercial Finance Corp. (OCFN) Small Cap Merger & Acquisition Strategy is Taking Traction

Omega Commercial Finance Corp. announced its execution of an LOI to acquire an operational brokerage firm last week, which will shape its small-cap growth strategy to provide capital for implementing their lending platforms. Fundamentally, the integration of this brokerage firm will sustain long-term year-over-year projected growth for its lending operations by 20% and a projected EPS of $.02, based on the B/D’s historical net profits of $650,000 per year. Subsequently, with an industry small-cap benchmark PE/ratio of 25x could result in a forecasted market price of $.50/share. Omega formed in 2004 as a private commercial real estate finance broker. As…

Site Search

Company Search

Month: September 2012